AP
WST icon

Advisors Preferred’s West Pharmaceutical WST Stock Holding History

Advisors Preferred’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,410
Closed -$1.43M – 241
2021
Q3 		$1.43M Buy
+3,410
New +$1.44M 0.2% 49
2020
Q4 		– Sell
-6,466
Closed -$1.78M – 211
2020
Q3 		$1.78M Buy
+6,466
New +$1.71M 0.35% 25
2015
Q1 		– Sell
-12,599
Closed -$671K – 356
2014
Q4 		$671K Buy
+12,599
New +$630K 0.32% 79

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advisors Preferred's WST Position: Q4 2021 in Review

Advisors Preferred sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 3,410 shares — an estimated $1.43M sold.

Advisors Preferred first reported a position in WST in Q4 2014 and held it in 3 quarters. The position peaked at $1.78M in Q3 2020. 730 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • Advisors Preferred reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Advisors Preferred sold 3,410 West Pharmaceutical shares in Q4 2021, an estimated $1.43M.
  • Advisors Preferred first reported a position in West Pharmaceutical in Q4 2014 and held it in 3 quarters.
  • Advisors Preferred's West Pharmaceutical position peaked at $1.78M in Q3 2020.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Advisors Preferred's 13F filing for Q4 2021, filed 7 Feb 2022.